PLEC and neoplasm: To identify potential molecular effectors and signaling pathways mediating the tumor suppressive effects of plectin inactivation, we profiled the proteomes of WT, KO, and PST-treated WT SNU-475 cells using MS-based shotgun proteomics and phosphoproteomics (Figure 3A–C; Figure 3—figure supplement 1A and B).